ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/08/2026
Back to search
Official data from USPTO
ZYLORION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ZYLORION
ST13
US500000097102047Class
5, 9, 29, 31, 35, 41, 42, 44
Filing
97102047
Registration
8320275
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
59
Latest update
07/08/2026
Trademark type
Word
Nice classes
5, 9, 29, 31, 35, 41, 42, 44
Filing date
11/01/2021
Registration date
06/30/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/30/2026
Last transaction
07/08/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
CALGARY, CA
Examiner
MCCAULEY, BRENDAN D
Law office
P10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
ZYLORION HEALTH INC.
PsiloTec Health Solutions Inc.
Representatives
Charles G. Zug NELSON MULLINS RILEY & SCARBOROUGH LLP
Technical classification
Nice Classes
Class 5Class 9Class 29Class 31Class 35Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Psychedelic medicines for the treatment of psychiatric diseasesmood disordersdepressionmood and emotional instability disorders; psychedelic medicines for the treatment of addiction disordersalcohol abusedrug abuseeating disordersgambling addiction and sex addiction; psychedelic medicines for the treatment of anxiety disorderssocial anxietygeneralized anxiety and panic attack disorder; psychedelic medicines for the treatment of psychological traumapost-traumatic stress disorderoccupational stress injurybullyingemotional traumaphysical traumawork traumafamily violence and grief; psychedelic medicines for the treatment of physical traumapost-burn injurypost-spinal-cord injuryadult post-amputationpost-brain injury and post-stroke; psychedelic medicines for the treatment of chronic painmigraineschronic back pain and chronic arthritis; psychedelic medicines for the treatment of cognitive diseasescognitive deteriorationearly dementia and age-associated memory impairment; psychedelic medicines for the treatment of neuropsychiatric disordersadult fetal alcohol spectrum disorderadult attention deficit disorderadult autismpost-stroke symptomsmultiple sclerosis and Parkinson's disease; psychedelic medicines for the treatment of sleep related disorderschronic fatigue syndromefatigue and insomnia; psychedelic medicines for the treatment of mental health problems experienced by indigenous and other marginalized communities; psychedelic medicines for the treatment of covid-19 symptoms and syndromes
Class 9
Downloadable computer application software for mobile phones for clinical interactionsscheduling appointmentssubmitting feedbackmeasuring feedback from biometricssuch as pulse and heart ratestoring forms and questionnaires in connection with providing therapy services to individuals in the fields of psychiatric diseasesaddiction disordersanxiety disorderspsychological traumaphysical traumachronic paincognitive diseasesneuropsychiatric disorderssleep related disordersmental health problems experienced by indigenous and other marginalized communitiescovid-19 symptoms and syndromes; downloadable computer software for clinical interactionsscheduling appointmentssubmitting feedbackmeasuring feedback from biometricssuch as pulse and heart ratestoring forms and questionnaires in connection with providing therapy services to individuals in the fields of psychiatric diseasesaddiction disordersanxiety disorderspsychological traumaphysical traumachronic paincognitive diseasesneuropsychiatric disorderssleep related disordersmental health problems experienced by indigenous and other marginalized communitiescovid-19 symptoms and syndromes
Class 29
Dried edible mushrooms
Class 31
Fresh edible mushrooms
Class 35
Data processing services of medical data relating to psychiatric diseasesaddiction disordersanxiety disorderspsychological traumaphysical traumachronic paincognitive diseasesneuropsychiatric disorderssleep related disordersmental health problems experienced by indigenous and other marginalized communitiescovid-19 symptoms and syndromes; compiling medical data for business purposes relating to psychiatric diseasesaddiction disordersanxiety disorderspsychological traumaphysical traumachronic paincognitive diseasesneuropsychiatric disorderssleep related disordersmental health problems experienced by indigenous and other marginalized communitiescovid-19 symptoms and syndromes
Class 41
Provision of training in the fields of psychiatric diseasesaddiction disordersanxiety disorderspsychological traumaphysical traumachronic paincognitive diseasesneuropsychiatric disorderssleep related disordersmental health problems experienced by indigenous and other marginalized communitiescovid-19 symptoms and syndromes; provision of education servicesproviding courses of instructionclassesseminarsworkshopsconferences in the fields of psychiatric diseasesaddiction disordersanxiety disorderspsychological traumaphysical traumachronic paincognitive diseasesneuropsychiatric disorderssleep related disordersmental health problems experienced by indigenous and other marginalized communitiescovid-19 symptoms and syndromes; provision of training in the field of psychedelic medicines; provision of education servicesproviding courses of instructionclassesseminarsworkshopsconferences and training in the field of psychedelic medicines
Class 42
Medical and scientific research and product development in the field of psychedelics; medical and scientific research in the fields of psychiatric diseasesaddiction disordersanxiety disorderspsychological traumaphysical traumachronic paincognitive diseasesneuropsychiatric disorderssleep related disordersmental health problems experienced by indigenous and other marginalized communitiescovid-19 symptoms and syndromes; providing medical and scientific research information in the field of clinical trials; conducting clinical trials for others in the fields of psychiatric diseasesaddiction disordersanxiety disorderspsychological traumaphysical traumachronic paincognitive diseasesneuropsychiatric disorderssleep related disordersmental health problems experienced by indigenous and other marginalized communitiescovid-19 symptoms and syndromes; laboratory scientific and medical research in the fields of psychiatric diseasesaddiction disordersanxiety disorderspsychological traumaphysical traumachronic paincognitive diseasesneuropsychiatric disorderssleep related disordersmental health problems experienced by indigenous and other marginalized communitiescovid-19 symptoms and syndromes; providing temporary use of non-downloadable computer software for clinical interactionsscheduling appointmentssubmitting feedbackmeasuring feedback from biometricssuch as pulse and heart ratestoring forms and questionnaires in connection with providing therapy services to individuals in the fields of psychiatric diseasesaddiction disordersanxiety disorderspsychological traumaphysical traumachronic paincognitive diseasesneuropsychiatric disorderssleep related disordersmental health problems experienced by indigenous and other marginalized communitiescovid-19 symptoms and syndromes; compiling medical and scientific research data in the fields of psychiatric diseasesaddiction disordersanxiety disorderspsychological traumaphysical traumachronic paincognitive diseasesneuropsychiatric disorderssleep related disordersmental health problems experienced by indigenous and other marginalized communitiescovid-19 symptoms and syndromes
Class 44
Psychotherapy services; mental health therapy services for the treatment of psychiatric diseasesaddiction disordersanxiety disorderspsychological traumaphysical traumachronic paincognitive diseasesneuropsychiatric disorderssleep related disordersmental health problems experienced by indigenous and other marginalized communitiescovid-19 symptoms and syndromes; provision of information to others in the field of mental health; clinical mental health counselling services; compiling medical health information data in the fields of psychiatric diseasesaddiction disordersanxiety disorderspsychological traumaphysical traumachronic paincognitive diseasesneuropsychiatric disorderssleep related disordersmental health problems experienced by indigenous and other marginalized communitiescovid-19 symptoms and syndromes
Publications
History of USPTO decisions and trademark events.
59 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/30/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
06/30/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/12/2026
PUBO
PUBLISHED FOR OPPOSITION
05/12/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/06/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/14/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/13/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/13/2026
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/13/2026
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
01/12/2026
GNSI
INQUIRY TO SUSPENSION E-MAILED
01/12/2026
CNSI
SUSPENSION INQUIRY WRITTEN
01/12/2026
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
10/17/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/16/2025
GNSL
LETTER OF SUSPENSION E-MAILED
04/16/2025
CNSL
SUSPENSION LETTER WRITTEN
04/16/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/16/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/16/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/15/2025
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
01/15/2025
GNSI
INQUIRY TO SUSPENSION E-MAILED
01/15/2025
CNSI
SUSPENSION INQUIRY WRITTEN
01/15/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/17/2024
GNSL
LETTER OF SUSPENSION E-MAILED
07/17/2024
CNSL
SUSPENSION LETTER WRITTEN
07/17/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/16/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/16/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/16/2024
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
04/17/2024
GNSI
INQUIRY TO SUSPENSION E-MAILED
04/17/2024
CNSI
SUSPENSION INQUIRY WRITTEN
04/17/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/19/2023
GNSL
LETTER OF SUSPENSION E-MAILED
10/19/2023
CNSL
SUSPENSION LETTER WRITTEN
10/19/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/19/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/19/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/19/2023
ALIE
ASSIGNED TO LIE
10/19/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/22/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/23/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/23/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/23/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/23/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
02/22/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
02/22/2023
CNSI
SUSPENSION INQUIRY WRITTEN
02/22/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/25/2022
GNSL
LETTER OF SUSPENSION E-MAILED
08/25/2022
CNSL
SUSPENSION LETTER WRITTEN
08/25/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/20/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/19/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/19/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/12/2022
GNRT
NON-FINAL ACTION E-MAILED
08/12/2022
CNRT
NON-FINAL ACTION WRITTEN
08/12/2022
DOCK
ASSIGNED TO EXAMINER
08/10/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/11/2021
NWAP
NEW APPLICATION ENTERED
11/04/2021
Continuous trademark protection
Get notified about every new filing that threatens ZYLORION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.